Mechanism Profile 2006 Phase 2 mechanism profile (academic record) Diamond and colleagues (J Sex Med 2006) characterized the compound as a synthetic peptide melanocortin analog of alpha-melanocyte-stimulating hormone, reported to act as an agonist at melanocortin receptors MC3R and MC4R
Qty in Cart: 0 Price: MRP: 13,791.00 Price: 10,609.00 Tesseract Medical Research QuerciSorb SR Immune Support Supplement and Tetracumin SR Sustained Release Joint & Muscle Supplement MRP: 24,845.00 Price: 19,876.00 Based on the most radical advancement in nutrient delivery technology in medical history, Tesseract is bringing to market a large portfolio of unique, breakthrough products that are already forming
hence, more studies are needed to be done to clearly identify this interaction
Furthermore, the Dead Sea is known to have therapeutic potential for treating AD
The coenzymes of this vitamin are highly unstable in light
The study highlights GHRP-2s distinct mechanisms of action in treating obesity, including targeted fat reduction and appetite control, by contrasting it with other peptides, including AOD-9604, Tesamorelin, and Tesofensine